News

Video

Expert: The National Blood Shortage Is Forcing Hospitals to Make Difficult Decisions Regarding Which Patients Get Blood

Jennifer Andrews, MD, pediatric hematologist-oncologist at Vanderbilt University Medical Center and medical director of Vanderbilt University Medical Center’s blood bank, discusses what the national blood shortage may mean for health systems.

Pharmacy Times interviewed Jennifer Andrews, MD, a pediatric hematologist-oncologist at Vanderbilt University Medical Center and the medical director of the blood bank, on the national blood shortage in the United States. As the national inventory was beginning to recover toward the end of this summer, COVID-19 cases began to significantly increase as a result of the Delta variant, directly impacting donor turnout.

During the discussion, Andrews addressed what this blood shortage may mean for health systems.

Jennifer Andrews: It really means that at a hospital like Vanderbilt University Medical Center, which serves over a thousand patients every day and has the only level 1 trauma center in Nashville, a big city. It means that we have to be thoughtful about which patients get blood that day.

We've also had to, just like at the beginning of the COVID-19 pandemic, delay certain surgeries that our surgeons knew those patients had a high risk of bleeding, and I, myself, as a hematologist, have had to delay needed transfusions for some of my patients, for example, with anemias where there's no alternate therapy for that blood transfusion.

Related Videos
Anthony Perissinotti, PharmD, BCOP, discusses unmet needs and trends in managing chronic lymphocytic leukemia (CLL), with an emphasis on the pivotal role pharmacists play in supporting medication adherence and treatment decisions.
pharmacogenetics testing, adverse drug events, personalized medicine, FDA collaboration, USP partnership, health equity, clinical decision support, laboratory challenges, study design, education, precision medicine, stakeholder perspectives, public comment, Texas Medical Center, DNA double helix
Pharmacy, Advocacy, Opioid Awareness Month | Image Credit: pikselstock - stock.adobe.com
pharmacogenetics challenges, inter-organizational collaboration, dpyd genotype, NCCN guidelines, meta census platform, evidence submission, consensus statements, clinical implementation, pharmacotherapy improvement, collaborative research, pharmacist role, pharmacokinetics focus, clinical topics, genotype-guided therapy, critical thought
Hurricane Helene, Baxter plant, IV fluids shortage, health systems impact, injectable medicines, compounding solutions, patient care errors, clinical resources, operational consideration, fluid conservation, sterile water, temperature excursions, training considerations, patient safety, feedback request
Image Credit: © Andrey Popov - stock.adobe.com
Image Credit: © peopleimages.com - stock.adobe.com
Pharmacists, Education, Advocacy, Opioid Awareness Month | Image Credit: Jacob Lund - stock.adobe.com